A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

NCT05506943 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancer
Cholangiocarcinoma
Gall Bladder Cancer
Ampullary Cancer

Interventions

DRUG: CTX-009
DRUG: Paclitaxel

Sponsor

Compass Therapeutics